Bristol-Myers Squibb has recalled 64m tablets of its Avalide blood pressure drug in the US and Puerto Rico over fears it has the potential for reduced efficacy.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at inVentiv, AMRI, ShangPharma and ERT.
NextPharma Technologies will be bought by Sun European Partners, the European adviser to US investment group Sun Capital Partners, in a deal announced late yesterday.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at BioDelivery Sciences, SOCMA and Sanofi-aventis.
A report claims that extended clinical trial data exclusivity would benefit pharmaceutical innovation, leading to over 200 extra drug approvals and to greater life expectancy in future decades.
Drug developers are “aggressively changing” research and development (R&D) methods in the pursuit of the next blockbuster, according to the Tufts Centre for the Study of Drug Development (Tufts CSDD).
United Parcel Service (UPS) will open four global healthcare distribution centres to accommodate its fast growing healthcare business and a rising global customer base.
Spectrum Pharmaceuticals and Viropro are to develop a biosimilar version of rituximab, a monoclonal antibody cancer treatment sold by Roche and Biogen Idec.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including a departure at the US FDA’s principal deputy commissioner and appointments at Cephalon, AstraZeneca and Biogen Idec.
Merck KGaA has opened a new centre in India to showcase its range of technology solutions to the country’s rapidly expanding pharmaceutical and cosmetics industries.
Indian drugmaker Dr Reddy’s Laboratories has formed a manufacturing partnership with R-Pharm in a bid to strengthen its position in Russia’s fast-growing drug market.
The US FDA has finally become a member of the Pharmaceutical Inspection Convention and Pharmaceutical Co-Operation Inspection Scheme (PIC/S) after a five-year application process.
Followed the news in 2010? Then test your knowledge of biopharm in 2010 against colleagues, peers and our community of readers in our exclusive map-based quiz.
PR-based strategies emphasising the cost of the disease and local partners are needed to enter the lucrative German vaccine market, according to researchers.
Outsourcing-Pharma presents five of our top audio-visual articles of 2010, including a timeline of Lilly’s outsourcing, the need for US capacity and why biomarkers are indispensible.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Catalent, Quintiles, ACM and Premier Research.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including a new head of vaccines at Sanofi and another exec moving from Pfizer to AstraZeneca.
in-PharmaTechnologist presents five of our top audio-visual articles of 2010, including a map of Pfizer’s plant closures, gangsters in the pharma industry and a look inside SAFC’s HPAPI plant.
INC Research has shifted its headquarters to new and larger offices as part of the firm’s wider plan to ramp up its clinical trials outsourcing operations in Research Triangle, US.
Russia is “becoming dependant” on foreign drugmakers according to Prime Minister Vladimir Putin, who has called for home-grown manufacturers to make more of the country’s medicines.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at PharmaNet, PPD, BASi and WorldCare Clinical.
The EU and India have resolved a dispute about the seizure of generic medicines passing through Europe on route to Africa and Latin America, according to reports.
Pfizer hired investigators to expose corrupt behaviour of the former Nigerian attorney general to ‘pressure’ him to drop legal action against the contentious Trovan drug trial, according to a leaked US embassy cable.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including a new chairman at PhRMA and appointments at McKesson, Elan and GeoVax.
Australian Pharmaceutical Industries (API) and Sigma Pharmaceuticals shares’ have been hit by Pfizer’s decision to abandon wholesale distributors in favour of selling drugs direct to pharmacies.
WikiLeaks has published a list of overseas biopharmaceutical facilities considered vital to US national security as part of its release of leaked diplomatic cables.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including the departure of Patheon’s CEO and a number of promotions at Covance.
The shift towards a complex global supply chain incorporating many suppliers and service providers is driving adoption of modern analytical methods to ensure quality.
Only multiple anti-counterfeiting strategies are able to beat increasingly sophisticated criminals, according to a seminar on anti-counterfeiting at the recent AAPS trade event in New Orleans.
Pfizer will lay off 186 employees at its Vonore, US plant, as it intends to hand over the unit to the third-party logistics service provider, Exel, and outsource it logistics and distribution operations.
US based healthcare distributer, Cardinal Health, has announced the $470m acquisition of privately held healthcare distribution business Zuellig Pharma China, known locally as Yong Yu.
